Mon. 4 Mar 2024, 2:01pm ET
Benzinga
Biotech, News, General
Better Choice Company (NYSE:BTTR) ("Better Choice" or "the Company"), a pet health and wellness company, today announced that after successfully completing the acquisition of Aimia, the Company will explore and evaluate proposals to monetize and fund ownership in its R&D platform with the goal to bring in partners to participate in the evolution of a treat-based GLP1 supplement to combat obesity in dogs and cats.